TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.Appearance:SolidIC50&: Target:TrkAIn Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1%